Enhanced DNA repair and resistance to cisplatin in human ovarian cancer.
Lai
G M
GM
Medicine Branch, National Cancer Institute, Bethesda, MD 20892.
Ozols
R F
RF
Smyth
J F
JF
Young
R C
RC
Hamilton
T C
TC
D016590:Aphidicolin; D002945:Cisplatin / Q000633:toxicity*; D004260:DNA Repair / Q000187:drug effects*; D004224:Diterpenes / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics*; D014407:Tumor Cells, Cultured
D004224:Diterpenes; D016590:Aphidicolin; D002945:Cisplatin